English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
康諾思騰(Cornerstone Robotics)完成新一輪約2億美元超募融資
Nov 10, 2025 08:46 HKT
Market Value Lower Than Cash Assets? It's Time to Reevaluate NIVF
Nov 06, 2025 21:36 HKT
「非洲消費品製造第一股」招股進行中:頂流機構加持
Nov 04, 2025 17:13 HKT
「非洲消费品制造第一股」招股进行中:顶流机构加持
Nov 04, 2025 17:13 HKT
TruMerit 公司彼得·普雷佐西当选为联合国咨商地位非政府组织会议主席
Oct 31, 2025 10:00 HKT
TruMerit 公司彼得·普雷佐西當選為聯合國諮商地位非政府組織會議主席
Oct 31, 2025 10:00 HKT
全球首創抗炎代謝調節劑HTD1801完成2型糖尿病III期臨床研究 展現持續52周的綜合獲益與安全性優勢
Oct 31, 2025 08:30 HKT
???????????HTD1801??2????III????? ????52????????????
Oct 31, 2025 08:30 HKT
TruMerit's Peter Preziosi Elected President of the Conference of NGOs in Consultative Relationship With the United Nations
Oct 31, 2025 04:00 HKT
CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
Oct 30, 2025 20:00 HKT
康哲药业(867.HK;8A8.SG)长效抗IL-4Rα人源化单抗注射液MG-K10特应性皮炎适应症中国NDA已获受理
Oct 30, 2025 18:27 HKT
康哲藥業(867.HK;8A8.SG)長效抗IL-4Rα人源化單抗注射液MG-K10特應性皮炎適應症中國NDA已獲受理
Oct 30, 2025 18:27 HKT
Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders
Oct 30, 2025 16:48 HKT
云顶新耀与Visara签订协议 将在大中华区及其他亚洲市场开发及商业化VIS-101
Oct 30, 2025 16:36 HKT
雲頂新耀與Visara簽訂協議 將在大中華區及其他亞洲市場開發及商業化VIS-101
Oct 30, 2025 16:36 HKT
康哲藥業(867.HK; 8A8.SG)簽訂眼科藥物諾適得(R)與倍優適(R)經銷協議
Oct 28, 2025 18:22 HKT
CMS (867.HK; 8A8.SG) Signed A Distribution Agreement for Ophthalmic Drugs Lucentis(R) and Beovu(R)
Oct 27, 2025 22:00 HKT
Cambridge Isotope Laboratories, Inc. Unveils ISOAPI-D - a New Standard in Deuterated Reagents for Pharmaceutical Innovation - at CPhI Frankfurt 2025
Oct 27, 2025 21:00 HKT
Cambridge Isotope Laboratories, Inc. 在 2025 年法蘭克福國際製藥原料展(CPhI Frankfurt 2025)推出 ISOAPI-D —— 去氘試劑的新標準,推動製藥創新
Oct 27, 2025 21:00 HKT
Cambridge Isotope Laboratories, Inc. 與 Chemtatva Chiral Solutions Pvt. Ltd. 將在印度海得拉巴(Hyderabad)成立 Cambridge Isotope Laboratories, Pvt. Ltd.
Oct 27, 2025 20:45 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: